Get started
Author

Kouji Iida

Observed names: K Iida, K. Iida, KOUJI IIDA, Kouji IIDA
Institution: Shimane University
ORCID: 0000-0002-3121-0655
Observed ORCID: 0000-0002-3121-0655
OpenAlex ID: A5027372184
Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
2011 · Atsuko Katagiri, Kentaro Nakayama, et al. · Modern Pathology · 213
PDF
Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer
2010 · Naomi Nakayama, Kentaro Nakayama, et al. · Cancer · 209
Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
2017 · Hitomi Yamashita, Kentaro Nakayama, et al. · Oncotarget · 139
PDF
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
2008 · N Nakayama, K Nakayama, et al. · British Journal of Cancer · 114
PDF
EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target
2011 · K Iida, K Nakayama, et al. · British Journal of Cancer · 80
PDF
CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas
2015 · KENTARO NAKAYAMA, MOHAMMED TANJIMUR RAHMAN, et al. · International Journal of Oncology · 71
PDF
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma
2012 · Munmun Rahman, Kentaro Nakayama, et al. · Human Pathology · 68
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
2011 · Mohammed Tanjimur Rahman, Kentaro Nakayama, et al. · Cancer · 66
Notch3 Overexpression as Potential Therapeutic Target in Advanced Stage Chemoresistant Ovarian Cancer
2012 · Mohammed Tanjimur Rahman, Kentaro Nakayama, et al. · American Journal of Clinical Pathology · 65
Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes
2010 · Shamima Yeasmin, Kentaro Nakayama, et al. · Gynecologic Oncology · 45
ABTB/POZGene,NAC-1, a Tumor Recurrence–Associated Gene, as a Potential Target for Taxol Resistance in Ovarian Cancer
2008 · Masako Ishibashi, Kentaro Nakayama, et al. · Clinical Cancer Research · 44
PDF
Expression of the Bric-a-Brac Tramtrack Broad Complex Protein NAC-1 in Cervical Carcinomas Seems to Correlate with Poorer Prognosis
2008 · Shamima Yeasmin, Kentaro Nakayama, et al. · Clinical Cancer Research · 41
Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas
2011 · Shamima Yeasmin, Kentaro Nakayama, et al. · Human Pathology · 40
Biological role and prognostic significance of NAC1 in ovarian cancer
2010 · Kentaro Nakayama, Mohammed Tanjimur Rahman, et al. · Gynecologic Oncology · 39
Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas
2012 · M T Rahman, K Nakayama, et al. · British Journal of Cancer · 38
PDF
ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
2018 · Emi Sato, Kentaro Nakayama, et al. · International Journal of Molecular Sciences · 31
PDF
Fatty Acid Synthase Is a Potential Therapeutic Target in Estrogen Receptor-/Progesterone Receptor-Positive Endometrioid Endometrial Cancer
2013 · Mohammed Tanjimur Rahman, Kentaro Nakayama, et al. · Oncology · 30
Relationship between Microsatellite Instability, Immune Cells Infiltration, and Expression of Immune Checkpoint Molecules in Ovarian Carcinoma: Immunotherapeutic Strategies for the Future
2019 · Hitomi Yamashita, Kentaro Nakayama, et al. · International Journal of Molecular Sciences · 29
PDF
KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas
2013 · Mohammed Rahman, Kentaro Nakayama, et al. · International Journal of Molecular Sciences · 28
PDF
Microwave endometrial ablation as an alternative to hysterectomy for the emergent control of uterine bleeding in patients who are poor surgical candidates
2008 · Shamima Yeasmin, Kentaro Nakayama, et al. · Archives of Gynecology and Obstetrics · 28
PDF
Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer
2012 · Munmun Rahman, Kentaro Nakayama, et al. · Human Pathology · 27
Frequent Loss of Tumor Suppressor ARID1A Protein Expression in Adenocarcinomas/Adenosquamous Carcinomas of the Uterine Cervix
2012 · Atsuko Katagiri, Kentaro Nakayama, et al. · International Journal of Gynecological Cancer · 26
Loss of MKK4 expression in ovarian cancer: A potential role for the epithelial to mesenchymal transition
2010 · Shamima Yeasmin, Kentaro Nakayama, et al. · International Journal of Cancer · 26
PDF
Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas
2015 · HIROSHI KATAGIRI, KENTARO NAKAYAMA, et al. · International Journal of Oncology · 25
PDF
High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma
2018 · Masako Ishikawa, Kentaro Nakayama, et al. · Human Pathology · 24
Works count: 80
Citation count: 1,987
H-index: 24
I10-index: 48
Year
Topic
Type